Moncrief J, Popovich R, Seare W, Moncrief D, Simmons V, Settle S, Simmons E
Austin Diagnostic Clinic, Texas, USA.
Adv Perit Dial. 1995;11:197-9.
Catheter exit-site infection continues to be a more common morbid event in patients undergoing peritoneal dialysis. Previous attempts to place a biointegration material at the next site have failed to reduce infection rates. This study reports the use of an innovative microporous silicone material placed as a cuff around the catheter at the exit site. The porous material has a pore-sized distribution that stimulates and facilitates capillary ingrowth into the pores. This capillary ingrowth prevents scar tissue formation, increases blood supply, and theoretically improves the immunological competence of the tissue at the vulnerable exit site. Twenty-five test catheters (12 using standard exit-site creation and 13 using the Moncrief-Popovich implantation technique) were implanted in a canine model. The exit-site infection rate in a canine model without the microporous material was 100% at 2 months. The corresponding results with the microporous material was 40% at 2 months. The majority of the test catheters showed progressive drying and healing at the exit site. Sixty percent of the catheters healed quickly and remained infection-free. Biointegration of the microporous material at the exit-site was demonstrated. Several exit site infections with the test catheters treated only with local therapy (without systemic or topical antibiotics) demonstrated progressive healing and secondary adequate biointegration. Because of these encouraging results, human studies were initiated, with the first human implant occurring in August, 1994. A 10-patient project is planned for the next year.
在接受腹膜透析的患者中,导管出口部位感染仍然是一种较为常见的发病事件。此前在下一个部位放置生物整合材料的尝试未能降低感染率。本研究报告了一种创新的微孔硅酮材料的应用,该材料作为袖套置于导管出口部位周围。这种多孔材料具有孔径分布,可刺激并促进毛细血管向内生长到孔隙中。这种毛细血管向内生长可防止瘢痕组织形成,增加血液供应,并在理论上提高易感染出口部位组织的免疫能力。在犬类模型中植入了25根测试导管(12根采用标准出口部位创建方法,13根采用蒙克里夫 - 波波维奇植入技术)。在没有微孔材料的犬类模型中,2个月时出口部位感染率为100%。使用微孔材料时,2个月时相应结果为40%。大多数测试导管的出口部位呈现逐渐干燥和愈合的情况。60%的导管愈合迅速且无感染。证明了微孔材料在出口部位的生物整合。一些仅接受局部治疗(未使用全身或局部抗生素)的测试导管引发的出口部位感染显示出逐渐愈合和继发性充分生物整合。由于这些令人鼓舞的结果,启动了人体研究,首例人体植入于1994年8月进行。计划明年开展一个涉及10名患者的项目。